US4680172A
(en)
*
|
1985-03-05 |
1987-07-14 |
Ciba-Geigy Corporation |
Devices and methods for treating memory impairment
|
US4765985A
(en)
*
|
1985-03-05 |
1988-08-23 |
Ciba-Geigy Corporation |
Devices and methods for treating memory impairment
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
US4666926A
(en)
*
|
1986-02-27 |
1987-05-19 |
Warner-Lambert Company |
Transdermal formulations
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US4861800A
(en)
*
|
1987-08-18 |
1989-08-29 |
Buyske Donald A |
Method for administering the drug deprenyl so as to minimize the danger of side effects
|
DE3729299A1
(de)
*
|
1987-09-02 |
1989-03-23 |
Beiersdorf Ag |
Transdermales therapeutisches system
|
US5994392A
(en)
|
1988-02-26 |
1999-11-30 |
Neuromedica, Inc. |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
US6107499A
(en)
*
|
1988-02-26 |
2000-08-22 |
Neuromedica, Inc. |
Dopamine analog amide
|
GB8807504D0
(en)
*
|
1988-03-29 |
1988-05-05 |
Sandoz Ltd |
Improvements in/relating to organic compounds
|
US5075314A
(en)
*
|
1988-10-27 |
1991-12-24 |
Leitman Esther M |
Antimicturition composition and novel method
|
US5075312A
(en)
*
|
1988-10-27 |
1991-12-24 |
Leitman Esther M |
Novel anti-micturition composition and method
|
DE3843239C1
(it)
*
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
DE3843238C1
(it)
*
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
CA2012192A1
(en)
*
|
1989-03-28 |
1990-09-28 |
Munir A. Hussain |
Intranasal administration of physostigmine and arecoline
|
NZ237241A
(en)
*
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
EP0523150A4
(en)
*
|
1990-04-06 |
1993-09-29 |
Pharmetrix Corporation |
Device and method for enhanced administration of physostigmine
|
US5931774A
(en)
*
|
1991-06-14 |
1999-08-03 |
Proxima Therapeutics, Inc. |
Inflatable devices for tumor treatment
|
US5429582A
(en)
*
|
1991-06-14 |
1995-07-04 |
Williams; Jeffery A. |
Tumor treatment
|
GB9118028D0
(en)
*
|
1991-08-21 |
1991-10-09 |
Secr Defence Brit |
Improved transdrmal formulations
|
TW224048B
(it)
*
|
1992-03-30 |
1994-05-21 |
Hoechst Roussel Pharma |
|
US5643928A
(en)
*
|
1992-10-21 |
1997-07-01 |
Pharmaco Behavioral Associates, Inc. |
Human body weight management
|
US5596007A
(en)
*
|
1992-05-18 |
1997-01-21 |
Pharmaco Behavioral Associates, Inc. |
Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
|
US5612357A
(en)
*
|
1992-05-18 |
1997-03-18 |
Pharmaco Behavioral Associates, Inc. |
Use of cotinine to assist in the cessation of tobacco smoking
|
US5869505A
(en)
*
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
DE4238223C1
(de)
|
1992-11-12 |
1994-05-26 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
|
US5573774A
(en)
*
|
1993-02-02 |
1996-11-12 |
Keenan; Robert M. |
Nicotine metabolites, nicotine dependence and human body weight
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
DE4342174C1
(de)
*
|
1993-12-10 |
1995-05-11 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
|
JP3908795B2
(ja)
*
|
1994-11-29 |
2007-04-25 |
久光製薬株式会社 |
ケトチフェン含有経皮投与製剤
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
DE19533089C1
(de)
*
|
1995-09-07 |
1997-05-22 |
Hexal Ag |
Tacrin-Pflaster
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
US5977174A
(en)
*
|
1997-11-26 |
1999-11-02 |
Neuromedica, Inc. |
Cholinergic compositions and uses thereof
|
US6197764B1
(en)
|
1997-11-26 |
2001-03-06 |
Protarga, Inc. |
Clozapine compositions and uses thereof
|
US6146656A
(en)
*
|
1998-01-22 |
2000-11-14 |
Nitto Denko Corporation |
Percutaneous absorption preparation
|
US6225444B1
(en)
|
1998-02-10 |
2001-05-01 |
Protarga, Inc. |
Neuroprotective peptides and uses thereof
|
JP3987655B2
(ja)
*
|
1998-03-03 |
2007-10-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗痴呆薬を含有した経皮適用製剤又は坐剤
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
ES2248107T3
(es)
|
1999-08-31 |
2006-03-16 |
Incyte San Diego Incorporated |
Benciliden-tiazolidindionas y analogos y su utilizacion en el tratamiento de la diabetes.
|
US7077859B2
(en)
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
AU2002252227A1
(en)
|
2001-03-07 |
2002-09-24 |
Maxia Pharmaceuticals, Inc. |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
|
WO2002072543A2
(en)
*
|
2001-03-08 |
2002-09-19 |
Maxia Pharmaceuticals, Inc. |
Rxr activating molecules
|
CA2340824A1
(en)
*
|
2001-03-14 |
2002-09-14 |
Ibm Canada Limited-Ibm Canada Limitee |
Method and system for application behavior analysis
|
JP4634694B2
(ja)
|
2001-03-23 |
2011-02-16 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪アルコール薬物複合体
|
WO2002076402A2
(en)
*
|
2001-03-23 |
2002-10-03 |
Protarga, Inc. |
Fatty amine drug conjugates
|
JP2005500379A
(ja)
*
|
2001-08-17 |
2005-01-06 |
インサイト サンディエゴ インコーポレーテッド |
異脂肪血症および高コレステロール血症を治療するオキシム誘導体
|
WO2003028723A1
(fr)
*
|
2001-09-27 |
2003-04-10 |
Saitama Daiichi Pharmaceutical Co., Ltd. |
Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus
|
AU2002352706A1
(en)
*
|
2001-11-15 |
2003-06-10 |
Maxia Pharmaceuticals, Inc. |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
|
AU2003235716A1
(en)
*
|
2002-01-17 |
2003-07-30 |
Lts Lohmann Therapie-Systeme Ag |
Method for neutralizing or recycling carrier materials for film-like coatings
|
US7102000B2
(en)
*
|
2002-03-08 |
2006-09-05 |
Incyte San Diego Inc. |
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
|
US7196108B2
(en)
*
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
US20040087576A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Haracz John L. |
Antimnemonic therapy for hypermemory syndromes
|
US20050014767A1
(en)
*
|
2003-01-29 |
2005-01-20 |
Magnus Pfahl |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
|
KR20060036896A
(ko)
*
|
2003-04-18 |
2006-05-02 |
인사이트 산 디에고 인코포레이티드 |
대사 장애, 암 및 다른 질병의 치료를 위한 치환된이소크로만 화합물
|
DE10338174A1
(de)
*
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050182044A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
CA2508585A1
(en)
*
|
2004-06-01 |
2005-12-01 |
Axonyx, Inc. |
Transdermal delivery system for treatment of cognitive disorders
|
EP1604686A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Axonyx, Inc. |
Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression
|
CA2586975A1
(en)
*
|
2004-11-10 |
2006-05-18 |
The Trustees Of Columbia University In The City Of New York |
Method for treatment of movement disorders
|
JP2007308403A
(ja)
*
|
2006-05-17 |
2007-11-29 |
Kenji Yoshida |
皮膚外用剤
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
WO2009142968A2
(en)
*
|
2008-05-20 |
2009-11-26 |
Olema Pharmaceuticals, Inc. |
Valproic acid salts
|
US9732324B2
(en)
|
2008-10-23 |
2017-08-15 |
Cornell University |
Anti-viral method
|
US10117936B2
(en)
|
2013-03-15 |
2018-11-06 |
Tonix Pharma Holdings Limited |
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
|
CA3083341A1
(en)
|
2017-12-11 |
2019-06-20 |
Tonix Pharma Holdings Limited |
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
|